COVID-19 Booster Vaccine Study
18 - 75 years
Trial length :
6 clinic visits
1 follow-up phone call
In this trial, we are evaluating the safety and tolerability of a new investigational booster vaccine to support further protection against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called “COVID‑19”) around the world.
No needles required – delivery of the booster in this trial will be done through new, needle-free technology.
This study will require 6 clinic visits and 1 telephone call over a twelve-month period.
To be eligible you must:
- You MUST be fully vaccinated (had both shots of either Pfizer or AstraZeneca) and had your last dose at least 3 months before receiving the trial study drug.
- Be a healthy male or healthy female who is not pregnant or who cannot bear children
- Aged 18-75 (inclusive)
- Have no history of alcohol or drug abuse